Related references
Note: Only part of the references are listed.Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study
Alexandre Louvet et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)
Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3
Pamela S. Belperio et al.
JOURNAL OF HEPATOLOGY (2019)
Comparison of the efficacy of sofosbuvir plus ribavirin in Chinese patients with genotype 3a or 3b HCV infectionn
Rui Huang et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD
Haesuk Park et al.
HEPATOLOGY (2018)
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Raymond T. Chung et al.
CLINICAL INFECTIOUS DISEASES (2018)
EASL Recommendations on Treatment of Hepatitis C 2018
JOURNAL OF HEPATOLOGY (2018)
Molecular evolution of hepatitis C virus in China: A nationwide study
K. Huang et al.
VIROLOGY (2018)
Satisfactory virological response and fibrosis improvement of sofosbuvir-based regimens for Chinese patients with hepatitis C virus genotype 3 infection: results of a real-world cohort study
Ya-Chao Tao et al.
VIROLOGY JOURNAL (2018)
Younger trend of cirrhosis incidence in genotype 3 HCV infected patients in Eastern China
Jie Lu et al.
JOURNAL OF MEDICAL VIROLOGY (2017)
Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution
Yu Zhang et al.
VIROLOGY JOURNAL (2017)
Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents
Barbara Bartolini et al.
VIRUSES-BASEL (2017)
Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis
Jan Sperl et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Sarah Blach et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada
A. Moshyk et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
Robust HCV Genotype 3a Infectious Cell Culture System Permits Identification of Escape Variants With Resistance to Sofosbuvir
Santseharay Ramirez et al.
GASTROENTEROLOGY (2016)
APASL consensus statements and recommendation on treatment of hepatitis C
Masao Omata et al.
HEPATOLOGY INTERNATIONAL (2016)
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C
Aude Desnoyer et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatitis C Virus Subtype and Evolution Characteristic Among Drug Users, Men Who Have Sex With Men, and the General Population in Beijing, China
Yang Jiao et al.
MEDICINE (2016)
DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting
Sandra Beinhardt et al.
TRANSPLANT INTERNATIONAL (2016)
Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes
Arnolfo Petruzziello et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
All-Oral 12-Week Treatment With Daclatasvir Plus Sofosbuvir in Patients With Hepatitis C Virus Genotype 3 Infection: ALLY-3 Phase III Study
David R. Nelson et al.
HEPATOLOGY (2015)
A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan
Heather Bennett et al.
HEPATOLOGY INTERNATIONAL (2015)
Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6
Wei Ju et al.
VIROLOGY JOURNAL (2015)
Hepatitis C virus infection: are there still specific problems with genotype 3?
Claire Gondeau et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource
Donald B. Smith et al.
HEPATOLOGY (2014)
Hepatitis C virus infection in end-stage renal disease and kidney transplantation
Patrizia Burra et al.
TRANSPLANT INTERNATIONAL (2014)
The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C Results From an Analysis of Data From a Department of Veterans Affairs Clinical Registry
Jeffrey McCombs et al.
JAMA INTERNAL MEDICINE (2014)
Treatment of patients with genotype 3 chronic hepatitis C- current and future therapies
Shiv K. Sarin et al.
LIVER INTERNATIONAL (2012)
HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis
G. Nkontchou et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Role of Hepatitis C virus genotype 3 in liver fibrosis progression - a systematic review and meta-analysis
A. Probst et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Hepatitis C virus genotype 3a infection and hepatocellular carcinoma: Pakistan experience
Muhammad Idrees et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Share Paper
